Shali Chen
Impact in
- Ophthalmology top 0.5%
- Retinal Diseases and Treatments
- Cancer Research top 1%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
Papers in
-
- Retinal Diseases and Treatments 18
-
- MicroRNA in disease regulation 8
- Cancer-related molecular mechanisms research 6
- Co-authors
- Subrata K Chakrabarti (64 shared papers)Biao Feng (37 shared papers)Zia Ali Khan (12 shared papers)Yuexiu Wu (8 shared papers)Prasanth Puthanveetil (2 shared papers)Subhrojit Sen (6 shared papers)Kara Mcarthur (2 shared papers)Terry Evans (5 shared papers)
- Journals
- Diabetes (6 papers)Diabetes/Metabolism Research and Reviews (6 papers)Investigative Ophthalmology & Visual Science (4 papers)PLoS ONE (4 papers)American Journal of Physiology-Endocrinology and Metabolism (4 papers)
- Partner nations
- CanadaChinaUnited States
In The Last Decade
Shali Chen
78 papers receiving 4.6k citations
Shali Chen's Hit Papers
Peers
Comparison fields: 5 of 90
- Ophthalmology 958
- Cancer Research 1.1k
- Geriatrics and Gerontology 142
- Clinical Biochemistry 162
- Nephrology 317
Countries citing papers authored by Shali Chen
This map shows the geographic impact of Shali Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shali Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shali Chen more than expected).
Fields of papers citing papers by Shali Chen
This network shows the impact of papers produced by Shali Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shali Chen. The network helps show where Shali Chen may publish in the future.
Co-authors
The 25 scholars most cited alongside Shali Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 80 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 320 | |
| 2 | 2011 | 290 | |
| 3 | 2003 | 249 | |
| 4 | 2009 | 189 | |
| 5 | 2011 | 183 | |
| 6 | 2013 | 181 | |
| 7 | lncRNA H19 prevents endothelial–mesenchymal transition in diabetic retinopathy Hit paper breakdown → | 2019 | 179 |
| 8 | 2014 | 177 | |
| 9 | 2000 | 151 | |
| 10 | 2003 | 144 | |
| 11 | 2009 | 141 | |
| 12 | 2018 | 136 | |
| 13 | 2017 | 124 | |
| 14 | 2000 | 121 | |
| 15 | 2003 | 119 | |
| 16 | 2015 | 118 | |
| 17 | 2014 | 117 | |
| 18 | 2006 | 99 | |
| 19 | 2008 | 99 | |
| 20 | 2005 | 94 |
About Shali Chen
Shali Chen is a scholar working on Ophthalmology, Cancer Research, Physiology, Clinical Biochemistry and Cardiology and Cardiovascular Medicine, having authored 80 papers that have together received 4.7k indexed citations. Recurring topics across this work include Retinal Diseases and Treatments (18 papers), Nitric Oxide and Endothelin Effects (17 papers), Cardiac Fibrosis and Remodeling (11 papers), MicroRNA in disease regulation (8 papers), Advanced Glycation End Products research (7 papers), Cancer-related molecular mechanisms research (6 papers), Cardiovascular Function and Risk Factors (5 papers) and Chronic Kidney Disease and Diabetes (4 papers). The work is most often cited by research in Ophthalmology (958 citations), Cancer Research (1.1k citations), Geriatrics and Gerontology (142 citations), Clinical Biochemistry (162 citations) and Nephrology (317 citations). Shali Chen has collaborated with scholars based in Canada, China and United States. Frequent co-authors include Subrata K Chakrabarti, Biao Feng, Zia Ali Khan, Yuexiu Wu, Prasanth Puthanveetil, Subhrojit Sen, Kara Mcarthur, Terry Evans, Saumik Biswas and John R. Gonder. Their work appears in journals such as Diabetes, Diabetes/Metabolism Research and Reviews, Investigative Ophthalmology & Visual Science, PLoS ONE and American Journal of Physiology-Endocrinology and Metabolism.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.